Subscribe to RSS
DOI: 10.1055/s-2002-35746
© Georg Thieme Verlag Stuttgart · New York
Mitral Valve Surgery in Patients with Poor Left Ventricular Function
Publication History
Received July 7, 2002
Publication Date:
28 November 2002 (online)
Abstract
Background: Mitral valve surgery for the correction of secondary mitral valve regurgitation (MR) in cardiomyopathy is associated with a poor outcome. Numerous studies have identified a severe left ventricular dysfunction as an indicator for a poor prognosis. The aim of the study was to asses the follow-up after mitral valve surgery and severe left ventricular dysfunction. Methods: Between 1994 and 2000, 31 patients with mitral regurgitation and a left ventricular ejection fraction of below thirty percent undergoing isolated repair (n = 16) or replacement (n = 15) were investigated. All patients received maximal drug therapy. Twenty-one patients were New York Heart Association (NYHA) class III and 10 were class IV. Follow-up with echocardiography, ECG, and chest x-ray was performed in 87 % of the survivors. The mean duration of follow-up was 39 ± 16 months. Results: The mean duration of ICU and hospital stay was 3.6 ± 2.1 days and 8.1 ± 5.4 days, respectively. The 1-, 2-, and 5-year survival rates were 91 %, 84 %, and 77 %, respectively. NYHA class improved from 3.3 ± 0.8 to 2.1 ± 0.7 at follow-up (p < 0.01). The ejection fraction improved from 23.1 ± 6.6 % to 36 ± 6.8 % at follow-up (p < 0.02). Freedom from readmission for heart failure was 85 %, 79 %, and 68 % at 1-, 2-, and 5 years, respectively. Conclusions: Mitral valve surgery improves left ventricular function and reduces heart failure severity in patients with MR and cardiomyopathy. High-risk mitral valve surgery may be an alternative to heart transplantation in selected patients.
Key words
Secondary mitral regurgitation - primary mitral regurgitation - cardiomyopathy - left ventricular dysfunction - follow-up - end-stage heart failure
References
- 1 Bolling S, Smolens I A, Pagani F D. Surgical alternatives for heart failure. J Heart Lung Transplant. 2001; 20 729-733
- 2 Enriquez-Sarano M, Tajik A J, Schaff H V, Orszulak T A, Bailey K R, Frye R L. Echocardiographic prediction of survival after surgical correction of organic mitral regurgitation. Circulation. 1994; 90 830-837
- 3 Bishay E S, McCarthy P M, Cosgrove D M, Hoercher K J, Smedira N G, Mukherjee D, White J, Blackstone E H. Mitral valve surgery in patients with severe left ventricular dysfunction. Eur J Cardio-thoracic Surg. 2000; 17 213-221
- 4 Dreyfus G, Milaiheanu S. Mitral valve repair in cardiomyopathy. J Heart Lung Transplant. 2000; 19 (8S) S73-S76
- 5 Blondheim D S, Jacobs L E, Kotler M N, Costacurta G A, Parry W R. Dilated cardiomyopathy with mitral regurgitation: decreased survival despite a low frequency of left ventricular thrombus. Am Heart J. 1991; 122 763-771
- 6 Anguita M, Arizon J M, Bueno G, Latre J M, Sancho M, Torres F, Gimenez D, Concha M, Valles F. Clinical and hemodynamic predictors of survival in patients aged less than 65 years with severe congestive heart failure secondary to ischemic or nonischemic dilated cardiomyopathy. Am J Cardiol. 1993; 72 413-417
- 7 Stevenson L W, Fowler M B, Schroeder J S, Stevenson W G, Dracup K A, Fond V. Poor survival of patients with idiopathic cardiomyopathy considered too well for transplantation. Am J Med. 1987; 83 871-876
- 8 Bolling S F, Deeb D M, Brunstring L A, Bach D S. Early outcome of mitral valve reconstruction in patients with end-stage cardiomyopathy. J Thorac Cardiovasc Surg. 1995; 109 676-683
- 9 Lee S J, Bay K S. Mortality risk factors associated with mitral valve replacement: a survival analysis of 10 year follow-up data. Can J Cardiol. 1991; 7 11-18
- 10 Lindblom D, Lindblom U, Qvist J, Lundstrom H. Long-term relative survival rates after heart valve replacement. J Am Coll Cardiol. 1990; 15 566-573
- 11 Weyman A E. Principles and practice of echocardiography. Philadelphia, PA: Lea and Febiger 1994: 575-624
- 12 Carpentier A. Cardiac valve surgery: the “French correction”. J Thorac Cardiovasc Surg. 1983; 86 323-337
- 13 Bolling S F, Deeb G M, Bach D S. Mitral valve reconstruction in elderly; Ischemic patients. Chest. 1996; 109 35-40
- 14 Jones E L, Weintraub W S, Craver J M, Guyton R A, Shen Y. Interaction of age and coronary disease after valve replacement: implications for valve selection. Ann Thorac Surg. 1994; 58 378-385
- 15 Ashraf S S, Shaukat N, Odom N, Keenan D, Grotte G. Early and late results following combined coronary bypass surgery and mitral valve replacement. Eur J Cardiothorac Surg. 1994; 8 57-62
- 16 Minale C, Messmer B J. Combination of mitral and coronary artery surgery. J Cardiovasc Surg. 1986; 27 480-487
- 17 Badhwar V, Bolling S F. Mitral valve surgery in the patient with left ventricular dysfunction. Sem Thorac Cardiovsc Surg. 2002; 14 133-136
- 18 Okita Y, Miki S, Kusuhara K, Ueda Y, Tahata T, Yamanaka K, Higa T. Analysis of left ventricular motion after mitral valve replacement with a technique of preservation of all chordae tendineae: comparison with conventional mitral valve replacement or mitral valve repair. J Thorac Cardiovasc Surg. 1992; 102 786-795
- 19 Smolens I A, Pagani F D, Bolling S F. Mitral valve repair in heart failure. Eur J Heart Fail. 2000; 2 365-371
- 20 Bolling S F, Pagani F D, Deeb G M, Bach D S. Intermediate-term outcome of mitral reconstruction in cardiomyopathy. J Thorac Cardiovasc Surg. 1998; 115 381-388
- 21 Bach D S, Bolling S F. Early improvement in congestive heart failure after correction of secondary mitral regurgitation in end-stage cardiomyopathy. Am Heart J. 1995; 129 1165-1170
Dr. med. Markus Rothenburger
Department of Thoracic and Cardiovascular Surgery, University Hospital Muenster
Albert-Schweitzer Straße 33
48129 Münster
Germany
Phone: +49 (251) 83-47 401
Fax: +49 (251) 83-48 316
Email: markus.rothenburger@thgms.uni-muenster.de